<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35598335</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1878-5905</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>286</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>16</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biomaterials</Title>
          <ISOAbbreviation>Biomaterials</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment.</ArticleTitle>
        <Pagination>
          <StartPage>121575</StartPage>
          <MedlinePgn>121575</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biomaterials.2022.121575</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0142-9612(22)00215-0</ELocationID>
        <Abstract>
          <AbstractText>Human in vitro hepatic models that faithfully recapitulate liver function are essential for successful basic and translational research. A limitation of current in vitro models, which are extensively used for drug discovery and toxicity testing, is the loss of drug metabolic function due to the low expression and activity of cytochrome P450 (CYP450) enzymes. Here, we aimed to generate human pluripotent stem cell-derived hepatic organoids (hHOs) with a high drug metabolic ability. We established a two-step protocol to produce hHOs from human pluripotent stem cells for long-term expansion and drug testing. Fully differentiated hHOs had multicellular composition and exhibited cellular polarity and hepatobiliary structures. They also displayed remarkable CYP450 activity and recapitulated the metabolic clearance, CYP450-mediated drug toxicity, and metabolism. Furthermore, hHOs successfully modeled Wilson's disease in terms of Cu metabolism, drug responses, and diagnostic marker expression and secretion. In conclusion, hHOs exhibit high capacity for drug testing and disease modeling. Hence, this hepatic model system provides an advanced tool for studying hepatic drug metabolism and diseases.</AbstractText>
          <CopyrightInformation>Copyright Â© 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Hyemin</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Im</LastName>
            <ForeName>Ilkyun</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jeon</LastName>
            <ForeName>Jang Su</ForeName>
            <Initials>JS</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kang</LastName>
            <ForeName>Eun-Hye</ForeName>
            <Initials>EH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea; Department of Human and Environmental Toxicology, University of Science and Technology, Daejeon, 34113, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Hyang-Ae</ForeName>
            <Initials>HA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jo</LastName>
            <ForeName>Seongyea</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea; Laboratory of Stem Cell Biology, Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, 02841, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Ji-Woo</ForeName>
            <Initials>JW</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Woo</LastName>
            <ForeName>Dong-Hun</ForeName>
            <Initials>DH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Stem Cell Research, NEXEL Co., Ltd., Seoul, 07802, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Choi</LastName>
            <ForeName>Young Jae</ForeName>
            <Initials>YJ</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Hyo Jin</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Stem Cell Biology, Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, 02841, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Han</LastName>
            <ForeName>Ji-Seok</ForeName>
            <Initials>JS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Advanced Toxicology Research, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Byoung-Seok</ForeName>
            <Initials>BS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Advanced Toxicology Research, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Jong-Hoon</ForeName>
            <Initials>JH</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Stem Cell Biology, Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, 02841, Republic of Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kim</LastName>
            <ForeName>Sang Kyum</ForeName>
            <Initials>SK</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea. Electronic address: sangkim@cnu.ac.kr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Park</LastName>
            <ForeName>Han-Jin</ForeName>
            <Initials>HJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea. Electronic address: hjpark@kitox.re.kr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Biomaterials</MedlineTA>
        <NlmUniqueID>8100316</NlmUniqueID>
        <ISSNLinking>0142-9612</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cytochrome P450</Keyword>
        <Keyword MajorTopicYN="N">Drug metabolism</Keyword>
        <Keyword MajorTopicYN="N">Hepatic organoid</Keyword>
        <Keyword MajorTopicYN="N">Liver</Keyword>
        <Keyword MajorTopicYN="N">Toxicity testing</Keyword>
        <Keyword MajorTopicYN="N">Wilson's disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>22</Day>
          <Hour>18</Hour>
          <Minute>6</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35598335</ArticleId>
        <ArticleId IdType="doi">10.1016/j.biomaterials.2022.121575</ArticleId>
        <ArticleId IdType="pii">S0142-9612(22)00215-0</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
